(Q36021075)

11 August 2017

1 reference

title

Preventing diseases of the prostate in the elderly using hormones and nutriceuticals (English)

1 reference

11 August 2017

Comhaire F

1

1 reference

11 August 2017

Mahmoud A

series ordinal

2

1 reference

11 August 2017

publication date

1 June 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

7

1 reference

11 August 2017

issue

2

1 reference

11 August 2017

page(s)

155-169

1 reference

Ethnicity and migration as determinants of human prostate size

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Effects of androgen deficiency and replacement on prostate zonal volumes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

High plasma estradiol-17beta levels in dogs with benign prostatic hyperplasia and azoospermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Endocrine environment of benign prostatic hyperplasia: prostate size and volume are correlated with serum estrogen concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Role of estrogens in human benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Upregulation of estrogen and androgen receptors modulate expression of FGF-2 and FGF-7 in human, cultured, prostatic stromal cells exposed to high concentrations of estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Occult prostate cancer in men with low serum testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

High-grade prostate cancer is associated with low serum testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Associations of serum testosterone with microvessel density, androgen receptor density and androgen receptor gene polymorphism in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Association between prostate cancer and serum testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

c-met proto-oncogene expression in benign and malignant human prostate tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Regulation of invasive potential of human prostate cancer cell lines by hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Overexpression and regulation of expression of scatter factor/hepatocyte growth factor in prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Epidemiologic association between prostatitis and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Meta-analysis of measures of sexual activity and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Sexual factors and the risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Sexual behaviour, STDs and risks for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Mitochondrial DNA alterations in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Urinary 8-hydroxydeoxyguanosine and its analogs as DNA marker of oxidative stress: development of an ELISA and measurement in both bladder and prostate cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Simultaneous generation of multiple mitochondrial DNA mutations in human prostate tumors suggests mitochondrial hyper-mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Azasteroids: structure-activity relationships for inhibition of 5 alpha-reductase and of androgen receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Hormonal effects of an orally active 4-azasteroid inhibitor of 5 alpha-reductase in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

The clinical development of a 5α-reductase inhibitor, finasteride

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Comparison of the efficacy and safety of finasteride in older versus younger men with benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

The influence of finasteride on the development of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Safety and tolerability of the dual 5alpha-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Are serum hormones associated with the risk of prostate cancer? Prospective results from the Massachusetts Male Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Effect of Finasteride, a 5α-Reductase Inhibitor on Prostate Tissue Androgens and Prostate-Specific Antigen*

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Androgen administration in middle-aged and ageing men: effects of oral testosterone undecanoate on dihydrotestosterone, oestradiol and prostate volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Will the experience with tamoxifen in breast cancer help define the role of antiandrogens in prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Meta-analysis of clinical trials of permixon in the treatment of symptomatic benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Human prostatic steroid 5α-reductase isoforms—A comparative study of selective inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Inhibition of type 1 and type 2 5alpha-reductase activity by free fatty acids, active ingredients of Permixon

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia: analysis of prostate volume and therapeutic outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Interactions between herbal medicines and prescribed drugs: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

The Lipidosterolic Extract fromSerenoa repens Interferes with Prolactin Receptor Signal Transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Phytoestrogens and diseases of the prostate gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Dietary genistein down-regulates androgen and estrogen receptor expression in the rat prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Estrogen and the risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Production and actions of estrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Phytoestrogens: potential endocrine disruptors in males.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Promotion of health by soy isoflavones: efficacy, benefit and safety concerns

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Detrimental effect of cancer preventive phytochemicals silymarin, genistein and epigallocatechin 3-gallate on epigenetic events in human prostate carcinoma DU145 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Effects of dietary genistein exposure during development on male and female CD (Sprague-Dawley) rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Differential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in healthy middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Cardiovascular effects of testosterone: implications of the "male menopause"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Androgens and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

The effect of flaxseed supplementation in processed foods on serum fatty acids and enterolactone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Comparative study of concentration of isoflavones and lignans in plasma and prostatic tissues of normal control and benign prostatic hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Risk of cardiovascular disease-related and all-cause death according to serum concentrations of enterolactone: Kuopio Ischaemic Heart Disease Risk Factor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Pretreatment serum level of testosterone as a prognostic factor in Japanese men with hormonally treated stage D2 prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Low serum testosterone level predicts worse response to endocrine therapy in Japanese patients with metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

The correlation between pretreatment serum hormone levels and treatment outcome for patients with prostatic cancer and bony metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Andropause: hormone replacement therapy in the ageing male

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Buccal absorption of testosterone and its esters using a bioadhesive tablet in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Pharmacokinetics, safety and tolerability of three dosage regimens of buccal adhesive testosterone tablets in healthy men suppressed with leuprorelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Evidence from the aged orchidectomized male rat model that 17beta-estradiol is a more effective bone-sparing and anabolic agent than 5alpha-dihydrotestosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Effect of nonsteroidal anti-inflammatory agents and finasteride on prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

A population-based study of daily nonsteroidal anti-inflammatory drug use and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Myristoleic acid, a cytotoxic component in the extract from Serenoa repens, induces apoptosis and necrosis in human prostatic LNCaP cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Soy intake and cancer risk: a review of the in vitro and in vivo data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Effect of flavonoids on cell cycle progression in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Effects of phytoestrogens on growth and DNA integrity in human prostate tumor cell lines: PC-3 and LNCaP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Comparative tissue-specific toxicities of 20 cancer preventive agents using cultured cells from 8 different normal human epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Diet and the duration of testosterone-dependent prostate cancer in Lobund-Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

The effect of isolated soy protein on plasma biomarkers in elderly men with elevated serum prostate specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Dietary trial in prostate cancer: Early experience and implications for clinical trial design

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

The effects of combined conventional treatment, oral antioxidants and essential fatty acids on sperm biology in subfertile men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Prostate carcinogenesis in N-methyl-N-nitrosourea (NMU)-testosterone-treated rats fed tomato powder, lycopene, or energy-restricted diets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Oxidative DNA damage in human lymphocytes: correlations with plasma levels of alpha-tocopherol and carotenoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Comparative uptake of alpha- and gamma-tocopherol by human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Gamma-tocopherol detoxification of nitrogen dioxide: superiority to alpha-tocopherol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

The future of prostate cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Lycopene and beta-carotene protect against oxidative damage in HT29 cells at low concentrations but rapidly lose this capacity at higher doses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

The association of fatty acids with prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Pine bark extract pycnogenol downregulates IFN-gamma-induced adhesion of T cells to human keratinocytes by inhibiting inducible ICAM-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Effect of bioflavonoids extracted from the bark of Pinus maritima on proinflammatory cytokine interleukin-1 production in lipopolysaccharide-stimulated RAW 264.7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Risk of acute coronary events according to serum concentrations of enterolactone: a prospective population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530412331284722

Effects of the sabal serrulata extract IDS 89 and its subfractions on 5 alpha-reductase activity in human benign prostatic hyperplasia

21 January 2018

0 references

Identifiers

DOI

10.1080/13685530412331284722

1 reference

11 August 2017

1 reference